The National Cancer Institute (NCI), Division of Cancer Treatment and Diagnosis (DCTD), Office of Cancer Clinical Proteomics Research (OCCPR) is offering the Proteogenomic Translational Research Centers (PTRCs) grant as part of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. This grant aims to leverage advancements in cancer proteomics and genomics to enhance understanding of the relationship between the proteome and genome in cancer. The grant will support research in comprehensive proteogenomic approaches, development of novel cancer diagnostics and therapeutics, and facilitate translation of research findings through public resources. Closing date for applications is July 30, 2021.
Opportunity ID: 332574
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-21-025 |
| Funding Opportunity Title: | Proteogenomic Translational Research Centers (PTRCs) for Clinical Proteomic Tumor Analysis Consortium (U01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 05, 2021 |
| Last Updated Date: | Apr 05, 2021 |
| Original Closing Date for Applications: | Jul 30, 2021 |
| Current Closing Date for Applications: | Jul 30, 2021 |
| Archive Date: | Sep 04, 2021 |
| Estimated Total Program Funding: | $4,600,000 |
| Award Ceiling: | $750,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Native American tribal governments (Federally recognized) Independent school districts Public housing authorities/Indian housing authorities County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) is a part of the NCI, Division of Cancer Treatment and Diagnosis (DCTD), Office of Cancer Clinical Proteomics Research (OCCPR), Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. This reissuance of the CPTAC program leverages recent advancements in cancer proteomics and genomics to better understand the complexity between the proteome and the genome in cancer and accelerate research in these areas by disseminating research resources for the scientific community. The program will continue to 1) support an increased understanding of cancer through comprehensive proteogenomic approaches, 2) expand support for the development of novel cancer diagnostics and therapeutics by implementing proteogenomic strategies to understand drug response and development of resistance in the context of a clinical trial, and 3) accelerate its translation through public resources (such as data, assays, images and reagents) that catalyze hypothesis-driven science. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-21-025.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00266366 | Jun 30, 2021 | Jul 30, 2021 | View |
Package 1
Mandatory forms
332574 RR_SF424_2_0-2.0.pdf
332574 PHS398_CoverPageSupplement_5_0-5.0.pdf
332574 RR_OtherProjectInfo_1_4-1.4.pdf
332574 PerformanceSite_2_0-2.0.pdf
332574 RR_KeyPersonExpanded_2_0-2.0.pdf
332574 PHS398_ResearchPlan_4_0-4.0.pdf
332574 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
332574 RR_Budget_1_4-1.4.pdf
332574 RR_SubawardBudget30_1_4-1.4.pdf
332574 PHS398_ModularBudget_1_2-1.2.pdf
332574 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
